Ibm Retirement Fund Alnylam Pharmaceuticals, Inc. Transaction History

Ibm Retirement Fund

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$120.42 - $169.29 $227,112 - $319,280	-1,886 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$127.18 - $173.91 $11,573 - $15,825	-91 Reduced 4.6%	1,886 $308,000
Q4 2021 Jan 19, 2022	SELL	$159.56 - $209.29 $216,363 - $283,797	-1,356 Reduced 40.68%	1,977 $335,000
Q3 2021 Oct 05, 2021	BUY	$169.75 - $207.73 $2,885 - $3,531	17 Added 0.51%	3,333 $629,000
Q2 2021 Jul 12, 2021	SELL	$128.63 - $176.89 $78,850 - $108,433	-613 Reduced 15.6%	3,316 $562,000
Q1 2021 Apr 22, 2021	SELL	$126.83 - $175.69 $42,741 - $59,207	-337 Reduced 7.9%	3,929 $555,000
Q4 2020 Jan 25, 2021	SELL	$122.97 - $147.0 $16,723 - $19,992	-136 Reduced 3.09%	4,266 $554,000
Q3 2020 Oct 16, 2020	BUY	$121.19 - $165.49 $130,279 - $177,901	1,075 Added 32.31%	4,402 $641,000
Q2 2020 Jul 08, 2020	BUY	$104.21 - $156.44 $14,693 - $22,058	141 Added 4.43%	3,327 $493,000
Q1 2020 Apr 07, 2020	BUY	$93.12 - $133.99 $91,536 - $131,712	983 Added 44.62%	3,186 $347,000
Q4 2019 Jan 07, 2020	BUY	$74.51 - $124.23 $164,145 - $273,678	2,203 New	2,203 $254,000
Q3 2018 Nov 07, 2018	SELL	$87.52 - $122.67 $203,484 - $285,207	-2,325 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $22,254 - $27,165	-252 Reduced 9.78%	2,325 $229,000
Q1 2018 May 10, 2018	BUY	$115.92 - $148.54 $298,725 - $382,787	2,577 New	2,577 $307,000

638

108M

2.33M

2.15M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.